Dupilumab as a novel steroid-sparing treatment for IgG4-related disease.
Simpson, Rachel S
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease. [electronic resource] - Annals of the rheumatic diseases 04 2020 - 549-550 p. digital
Publication Type: Case Reports; Letter
1468-2060
10.1136/annrheumdis-2019-216368 doi
Aged
Antibodies, Monoclonal, Humanized--therapeutic use
Asthma--complications
Dermatitis, Atopic--complications
Glucocorticoids--therapeutic use
Humans
Immunoglobulin G4-Related Disease--complications
Male
Male Urogenital Diseases--diagnostic imaging
Retroperitoneal Fibrosis--diagnostic imaging
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease. [electronic resource] - Annals of the rheumatic diseases 04 2020 - 549-550 p. digital
Publication Type: Case Reports; Letter
1468-2060
10.1136/annrheumdis-2019-216368 doi
Aged
Antibodies, Monoclonal, Humanized--therapeutic use
Asthma--complications
Dermatitis, Atopic--complications
Glucocorticoids--therapeutic use
Humans
Immunoglobulin G4-Related Disease--complications
Male
Male Urogenital Diseases--diagnostic imaging
Retroperitoneal Fibrosis--diagnostic imaging